Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 33 to 82 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
188.688\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28647\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
189.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.453\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28235\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
260.532\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.309\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.27519\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
322\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
204.641\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
160.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.2714\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
161.046\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2707\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
161.051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.27066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.642\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
161.068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.27053\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
325.586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
256.492\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26938\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
65.4586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
83.0461\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26868\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
133\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
105\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.26667\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
51\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
52\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
53\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.144\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
158.868\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
54\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-d. [source:swissprot;acc:p17535]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.941\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
158.941\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
55\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
320.927\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.434\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26134\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
266.856\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
336.233\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25998\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
57\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-4 subunit. [source:swissprot;acc:p50150]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
266.863\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25979\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-3 subunit. [source:swissprot;acc:p29798]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
336.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-8 subunit (gamma-9). [source:swissprot;acc:q9uk08]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
266.864\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.184\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25976\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
61\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 subunit. [source:swissprot;acc:p30670]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
336.182\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25975\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
62\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
266.865\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25974\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
336.178\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25973\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
266.868\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25965\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
267.136\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
336.077\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25807\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
336.075\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
267.139\vspace{3pt}}&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
70\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
267.142\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
336.074\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25804\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
71\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
267.144\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
336.073\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25802\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
288\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
362\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
76\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
77\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
254.692\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.668\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.2567\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
78\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
254.693\vspace{3pt}}}&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
79\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
80\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
254.691\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.25669\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
81\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
254.614\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25645\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
267.636\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
335.359\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25304\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/